M. Gabriela Reyes

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease

James B. Koprich, Tom H. Johnston, M. Gabriela Reyes et al. · Molecular Neurodegeneration · 2010 · 144 citations · Full text

Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein

James B. Koprich, Tom H. Johnston, Philippe Huot et al. · PLoS ONE · 2011 · 107 citations · Full text

Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers<i>In Vitro</i>and in the MPTP-Lesioned Primate:<i>R</i>-MDMA Reduces Severity of Dyskinesia, Whereas<i>S</i>-MDMA Extends Duration of ON-Time

Philippe Huot, Tom H. Johnston, Katie D. Lewis et al. · Journal of Neuroscience · 2011 · 83 citations · Full text

UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances l-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset

Philippe Huot, Tom H. Johnston, Katie D. Lewis et al. · Neuropharmacology · 2014 · 43 citations

L-dopa Anti-parkinsonian Action, Mixed Dopamine, Serotonin Re-uptake Inhibitor +10

The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset

Philippe Huot, Tom H. Johnston, Michael Gandy et al. · PLoS ONE · 2012 · 40 citations · Full text